Topline phase 3 SHASTA-3 and SHASTA-4 trial data show plozasiran reduced triglycerides by up to 81% and acute pancreatitis events by 78% in severe HTG.

Dr Bond and Dr Lau stated that hormone therapy may be appropriate when a woman is younger than 60 years or within 10 years of menopause. “In addition, she should have moderate to severe symptoms that ...

Precardioversion monitoring with smartphone photoplethysmography reduces same-day cardioversion cancellations for patients with AF.

The American Heart Association issued a scientific statement on deprescribing for patients with cardiovascular disease and polypharmacy.

Cannabis beverages are increasingly turning up in stores next to other beverages, and doctors warn the easy access is putting kids at risk.

Researchers compared the safety and efficacy profiles of oral P2Y12 inhibitors among patients receiving percutaneous coronary intervention.

Kalshi and AppliedXL launch a pilot prediction market for late-stage clinical trial outcomes and FDA decisions using objective public data sources.

Social prescribing, which connects people with support activities, may help adolescents waiting for specialist mental health services.

The American College of Cardiology issued a 2026 scientific statement on direct oral anticoagulants for the prevention of thrombotic events.

Center volume for fetal aortic valvuloplasty is not associated with technical success or complications but is linked to lower periprocedural death.

The second universal definition of heart failure moves away from specific EF cutoffs to classify patients into clinically actionable groups.

Benzodiazepine use among older U.S. adults decreased before the COVID-19 pandemic but plateaued thereafter, according to a research letter published online Jul ...